| Literature DB >> 35022501 |
Sivaneswari Selvarajoo1, Jonathan Wee Kent Liew1,2, Tock H Chua3, Wing Tan1, Rafdzah Ahmad Zaki4, Romano Ngui1, Wan Yusoff Wan Sulaiman1, Poo Soon Ong5, Indra Vythilingam6.
Abstract
Dengue remains a major public threat and existing dengue control/surveillance programs lack sensitivity and proactivity. More efficient methods are needed. A cluster randomized controlled trial was conducted for 18 months to determine the efficacy of using a combination of gravid oviposition sticky (GOS) traps and dengue non-structural 1 (NS1) antigen for early surveillance of dengue among Aedes mosquito. Eight residential apartments were randomly assigned into intervention and control groups. GOS traps were placed at the intervention apartments weekly to trap Aedes mosquitoes and these tested for dengue NS1 antigen. When dengue-positive pool was detected, the community were notified and advised to execute protective measures. Fewer dengue cases were recorded in the intervention group than the control. Detection of NS1-positive mosquitoes was significantly associated with GOS Aedes index (rs = 0.68, P < 0.01) and occurrence of dengue cases (rs = 0.31, P < 0.01). Participants' knowledge, attitude, and practice (KAP) toward dengue control indicated significant improvement for knowledge (P < 0.01), practice (P < 0.01) and total scores (P < 0.01). Most respondents thought this surveillance method is good (81.2%) and supported its use nationwide. Thus, GOS trap and dengue NS1 antigen test can supplement the current dengue surveillance/control, in alignment with the advocated integrated vector management for reducing Aedes-borne diseases.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35022501 PMCID: PMC8755775 DOI: 10.1038/s41598-021-04643-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Number of dengue cases per week between apartments nested under intervention and control groups (mean ± standard error).
| Intervention group | Control group | ||
|---|---|---|---|
| Suria | 0.09 ± 0.04* | Indah | 0.76 ± 0.28* |
| Park avenue | 0.18 ± 0.06* | Vista | 1.10 ± 0.32* |
| Impian | 0.22 ± 0.07* | Permai | 2.54 ± 0.67 |
| Harmoni | 1.36 ± 0.34 | Lestari | 4.44 ± 1.19 |
Akaike information Criterion (AIC) = 773.3. Degree of freedom (d.f) = 347.
*Significant difference P value (P < 0.05) in number of cases reported between groups as tested by Tukey’s method.
Dengue case ratio in intervention and control groups.
| Group | No. of blocks | 2017–2018 (case ratio in relation to total dengue cases in the state of Selangor: 29, 908 cases) | 2019–2020 (case ratio in relation to total dengue cases in the state of Selangor: 76, 299 cases) | Percentage of change in dengue case ratio (%) |
|---|---|---|---|---|
| Intervention | 35 | 3.18 × 10–3 | 1.91 × 10–3 | −39.9 |
| Control | 38 | 2.51 × 10–3 | 2.04 × 10–3 | −18.7 |
| Negative control | 35 | 2.01 × 10–3 | 2.33 × 10–3 | 15.9 |
Figure 1Temporal trend of GOS index weekly in (A) Intervention group and monthly, (B) control group throughout the study period. The black dotted curve is a trend decomposition of GOS Aedes index in the respective group.
Number of Ae. aegypti caught per trap per week in each floor in intervention and control groups (mean ± standard error).
| Intervention group (df = 5719) | Control group (df = 1180) | ||
|---|---|---|---|
| Ground | 0.95 ± 0.08* | Ground | 0.69 ± 0.12 |
| F1 | 1.11 ± 0.35* | F3 | 0.48 ± 0.09 |
| F2 | 1.13 ± 0.32* | F6 | 0.13 ± 0.10 |
| F3 | 0.56 ± 0.05 | F9 | 0.33 ± 0.18 |
| F5 | 0.33 ± 0.10 | F12 | 3.38 ± 1.48* |
| F8 | 0.34 ± 0.10 | F15 | 0.98 ± 0.59* |
| F11 | 0.21 ± 0.07 | ||
| F14 | 0.29 ± 0.09 | ||
| F17 | 0.36 ± 0.11 | ||
*Significant difference P value (P < 0.05) in number of Ae. aegypti per trap per week within group.
Figure 2Distribution of dengue serotypes in mosquito sample and dengue cases by week.
Figure 3Weekly GOS index, the onset of dengue cases and dengue NS1 positive pool throughout the study period in the intervention group.
Figure 4Map of study area at Damansara Damai. “Map data @2018 Google”.
Figure 5Flowchart of the study trial.